We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$176M
AUM Growth
+$107M
Cap. Flow
+$103M
Cap. Flow %
58.75%
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
PLAB icon
Photronics
PLAB
+$774K
3
EW icon
Edwards Lifesciences
EW
+$755K
4
MMS icon
Maximus
MMS
+$754K
5
TTEK icon
Tetra Tech
TTEK
+$745K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$197K
2
CSGP icon
CoStar Group
CSGP
+$197K
3
VIST icon
Vista Energy
VIST
+$197K
4
SKX
Skechers
SKX
+$196K
5
ALRS icon
Alerus Financial
ALRS
+$195K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.43%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMRN icon
226
BioMarin Pharmaceuticals
BMRN
$11.5B
$318K 0.18%
+4,526
New +$378K
GATX icon
227
GATX Corp
GATX
$6.55B
$318K 0.18%
+2,399
New +$330K
MBIN icon
228
Merchants Bancorp
MBIN
$2.19B
$317K 0.18%
7,042
+3,815
+118% +$169K
SEI
229
Solaris Energy Infrastructure
SEI
$3.31B
$315K 0.18%
+24,716
New +$294K
WM icon
230
Waste Management
WM
$95.9B
$314K 0.18%
+1,514
New +$316K
APPN icon
231
Appian
APPN
$1.74B
$313K 0.18%
9,175
+6,047
+193% +$196K
CBL
232
CBL Properties
CBL
$1.78B
$313K 0.18%
12,422
+4,180
+51% +$106K
CI icon
233
Cigna
CI
$76.6B
$313K 0.18%
903
+884
+4,653% +$304K
CHE icon
234
Chemed
CHE
$6.78B
$313K 0.18%
+520
New +$295K
CELC icon
235
Celcuity
CELC
$4.03B
$311K 0.18%
+20,875
New +$344K
SFL icon
236
SFL Corp
SFL
$1.59B
$311K 0.18%
26,900
+22,511
+513% +$269K
AROC icon
237
Archrock
AROC
$6.33B
$310K 0.18%
+15,300
New +$310K
EYPT icon
238
EyePoint Inc
EYPT
$1.02B
$309K 0.18%
+38,700
New +$340K
BIIB icon
239
Biogen
BIIB
$29.9B
$307K 0.17%
+1,584
New +$331K
ZWS icon
240
Zurn Elkay Water Solutions
ZWS
$8.07B
$305K 0.17%
8,495
+5,318
+167% +$168K
UI icon
241
Ubiquiti
UI
$31.8B
$305K 0.17%
+1,374
New +$251K
ABCL icon
242
AbCellera Biologics
ABCL
$1.62B
$305K 0.17%
+117,158
New +$325K
GBTG icon
243
American Express Global Business Travel
GBTG
$4.91B
$303K 0.17%
+39,458
New +$273K
CMCSA icon
244
Comcast
CMCSA
$79.1B
$303K 0.17%
+7,257
New +$286K
OSW icon
245
OneSpaWorld
OSW
$2.67B
$302K 0.17%
+18,318
New +$290K
URBN icon
246
Urban Outfitters
URBN
$5.99B
$302K 0.17%
+7,878
New +$320K
WCN
247
Waste Connections
WCN
$42.8B
$300K 0.17%
1,680
+1,151
+218% +$208K
TTMI icon
248
TTM Technologies
TTMI
$13.6B
$300K 0.17%
+16,454
New +$318K
KALU icon
249
Kaiser Aluminum
KALU
$2.67B
$300K 0.17%
+4,137
New +$318K
MEDP icon
250
Medpace
MEDP
$16.8B
$300K 0.17%
898
+582
+184% +$221K

Similar funds

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
  • EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
  • EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.